Cargando…

Mechanistic analysis of resveratrol in cardiac hypertrophy by network pharmacology and animal experiments

Resveratrol (Res) serves a protective role in hepatic, cardiovascular and autoimmune hypertrophic disease. However, the mechanisms by which Res ameliorates cardiac hypertrophy have not yet been fully elucidated. In the present study, network pharmacology was used to construct a network and perform e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Shan, Shen, Lei, Lin, Song, Xiao, Dan, Xiao, Wei, Yan, Pei-Mei, Zhang, Yan-Yan, Jia, Wei-Wei, Lin, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727583/ https://www.ncbi.nlm.nih.gov/pubmed/36052855 http://dx.doi.org/10.3892/mmr.2022.12840

Ejemplares similares

Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
por: Chen, Chen, et al.
Publicado: (2018)

Difluoromethylornithine attenuates isoproterenol-induced cardiac hypertrophy by regulating apoptosis, autophagy and the mitochondria-associated membranes pathway
por: Zhao, Yu, et al.
Publicado: (2021)

Resveratrol and Amyloid-Beta: Mechanistic Insights
por: Jia, Yongming, et al.
Publicado: (2017)

Update on Phytochemistry and Pharmacology of Naturally Occurring Resveratrol Oligomers
por: Shen, Jie, et al.
Publicado: (2017)

Combinational effect of resveratrol and atorvastatin on isoproterenol-induced cardiac hypertrophy in rats
por: Chakraborty, Songjukta, et al.
Publicado: (2015)

NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
por: Zhang, Xin, et al.
Publicado: (2020)

Identification of circular RNAs in cardiac hypertrophy and cardiac fibrosis
por: Chen, Yan, et al.
Publicado: (2022)

Role of CyPA in cardiac hypertrophy and remodeling
por: Cao, Mengfei, et al.
Publicado: (2019)

Pharmacological Effects of Resveratrol in Intervertebral Disc Degeneration: A Literature Review
por: Liu, Ming‐yang, et al.
Publicado: (2022)

Resveratrol Ameliorates Cardiac Hypertrophy by Down‐regulation of miR‐155 Through Activation of Breast Cancer Type 1 Susceptibility Protein
por: Fan, Yuhua, et al.
Publicado: (2016)

Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2016)

Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients
por: Zhang, Chen, et al.
Publicado: (2014)

Investigating the Mechanism of Hyperglycemia-Induced Fetal Cardiac Hypertrophy
por: Han, Sha-sha, et al.
Publicado: (2015)

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy through Activation of Autophagy
por: Chen, HuaLi, et al.
Publicado: (2013)

Corosolic acid ameliorates cardiac hypertrophy via regulating autophagy
por: Wang, Zhao-Peng, et al.
Publicado: (2019)

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
por: Deng, Ke-Qiong, et al.
Publicado: (2023)

Variations in the Levels of Mulberroside A, Oxyresveratrol, and Resveratrol in Mulberries in Different Seasons and during Growth
por: Zhou, Jin, et al.
Publicado: (2013)

Nuclear receptor corepressor 1 represses cardiac hypertrophy
por: Li, Chao, et al.
Publicado: (2019)

MicroRNA-327 regulates cardiac hypertrophy and fibrosis induced by pressure overload
por: Ji, Yue, et al.
Publicado: (2018)

Resveratrol promotes myogenesis and hypertrophy in murine myoblasts
por: Montesano, Anna, et al.
Publicado: (2013)

The role of post‐translational modifications in cardiac hypertrophy
por: Yan, Kaowen, et al.
Publicado: (2019)

Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload
por: Zhou, Heng, et al.
Publicado: (2011)

Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions
por: Liu, Ya, et al.
Publicado: (2021)

Quercetin Attenuates Cardiac Hypertrophy by Inhibiting Mitochondrial Dysfunction Through SIRT3/PARP-1 Pathway
por: Chen, Wen-Jing, et al.
Publicado: (2021)

Mechanistic Investigation of Xuebijing for Treatment of Paraquat-Induced Pulmonary Fibrosis by Metabolomics and Network Pharmacology
por: Wang, Tongtong, et al.
Publicado: (2021)

Rhein ameliorates transverse aortic constriction-induced cardiac hypertrophy via regulating STAT3 and p38 MAPK signaling pathways
por: Li, Run-Jing, et al.
Publicado: (2022)

Loganin Inhibits Angiotensin II–Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways
por: Xu, Jia-jia, et al.
Publicado: (2021)

Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights
por: de Sá Coutinho, Diego, et al.
Publicado: (2018)

Resveratrol activates endogenous cardiac stem cells and improves myocardial regeneration following acute myocardial infarction
por: Ling, Lin, et al.
Publicado: (2017)

ndufa7 plays a critical role in cardiac hypertrophy
por: Shi, Xingjuan, et al.
Publicado: (2020)

The function of LncRNA-H19 in cardiac hypertrophy
por: Su, Wenhua, et al.
Publicado: (2021)

Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol
por: Bezstarosti, Karel, et al.
Publicado: (2006)

Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking ELTD1
por: Xiao, Jinfeng, et al.
Publicado: (2012)

IKKi Deficiency Promotes Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Dai, Jia, et al.
Publicado: (2013)

Exercise Training Attenuates Hypertension and Cardiac Hypertrophy by Modulating Neurotransmitters and Cytokines in Hypothalamic Paraventricular Nucleus
por: Jia, Lin-Lin, et al.
Publicado: (2014)

Mechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer
por: Wang, Li-Yan, et al.
Publicado: (2020)

Effects of Sirt3-autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism
por: Wang, Hai-Ning, et al.
Publicado: (2020)

Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies
por: Hu, Heng-Chang, et al.
Publicado: (2022)

Ganoderma lucidum polysaccharides attenuates pressure-overload-induced pathological cardiac hypertrophy
por: Zhen, Changlin, et al.
Publicado: (2023)

Roles of Resveratrol in Improving the Quality of Postovulatory Aging Oocytes In Vitro
por: Sun, Yan-Li, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f8nn9juoruo3hgj934kgjmjbu6